drugset / Trial / NCT02111746

PAIN - Postoperative Analgesia INvestigation

NCT02111746

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the efficacy of the intraoperative injection of prolonged acting (liposomal) bupivacaine in postoperative pain control after truncal surgical incisions.

Timeline

Start
2013-11-20
Primary completion
2017-05-03
Completion
2017-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 125 mg Other
Subject Bupivacaine Other / unclassified 266 mg Other
Background Hydromorphone Other / unclassified 0.2 mg
Background Hydromorphone Other / unclassified 0.4 mg
Background Hydromorphone Other / unclassified 2 mg

Indications

No indication recorded.